These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 9930730

  • 1. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists.
    Kramer HK, Simon EJ.
    J Neurochem; 1999 Feb; 72(2):585-93. PubMed ID: 9930730
    [Abstract] [Full Text] [Related]

  • 2. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
    Kramer HK, Simon EJ.
    J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE, Harrison LM, Ge LJ, Kastin AJ, Chang SL.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
    [Abstract] [Full Text] [Related]

  • 4. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
    Breivogel CS, Selley DE, Childers SR.
    J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416
    [Abstract] [Full Text] [Related]

  • 5. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y, Gafni M, Keren O, Sarne Y.
    Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
    [Abstract] [Full Text] [Related]

  • 6. Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine.
    Chakrabarti S, Law PY, Loh HH.
    Brain Res Mol Brain Res; 1995 Jun; 30(2):269-78. PubMed ID: 7637578
    [Abstract] [Full Text] [Related]

  • 7. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG, Prather PL.
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [Abstract] [Full Text] [Related]

  • 8. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells.
    Horner KA, Zadina JE.
    Brain Res; 2004 Dec 03; 1028(2):121-32. PubMed ID: 15527737
    [Abstract] [Full Text] [Related]

  • 9. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
    Chakrabarti S, Law PY, Loh HH.
    J Neurochem; 1998 Jul 03; 71(1):231-9. PubMed ID: 9648870
    [Abstract] [Full Text] [Related]

  • 10. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR, Nahorski SR.
    Mol Pharmacol; 1995 Apr 03; 47(4):848-54. PubMed ID: 7723747
    [Abstract] [Full Text] [Related]

  • 11. Tolerance to mu-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5'-O-(3-[35S]-thio)triphosphate binding.
    Elliott J, Guo L, Traynor JR.
    Br J Pharmacol; 1997 Aug 03; 121(7):1422-8. PubMed ID: 9257923
    [Abstract] [Full Text] [Related]

  • 12. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC, Purohit V, Patel K, Zhang Q.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):87-96. PubMed ID: 15363980
    [Abstract] [Full Text] [Related]

  • 13. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
    Zadina JE, Chang SL, Ge LJ, Kastin AJ.
    J Pharmacol Exp Ther; 1993 Apr 13; 265(1):254-62. PubMed ID: 8097244
    [Abstract] [Full Text] [Related]

  • 14. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
    Wagner EJ, Rønnekleiv OK, Kelly MJ.
    J Pharmacol Exp Ther; 1998 Jun 13; 285(3):1266-73. PubMed ID: 9618432
    [Abstract] [Full Text] [Related]

  • 15. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
    Pak Y, Kouvelas A, Scheideler MA, Rasmussen J, O'Dowd BF, George SR.
    Mol Pharmacol; 1996 Nov 13; 50(5):1214-22. PubMed ID: 8913353
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N, Medzihradsky F.
    Mol Pharmacol; 1997 Nov 13; 52(5):896-902. PubMed ID: 9351981
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological profiles of selective non-peptidic delta opioid receptor ligands.
    Chaturvedi K, Jiang X, Christoffers KH, Chinen N, Bandari P, Raveglia LF, Ronzoni S, Dondio G, Howells RD.
    Brain Res Mol Brain Res; 2000 Sep 15; 80(2):166-76. PubMed ID: 11038249
    [Abstract] [Full Text] [Related]

  • 18. Naloxone activation of mu-opioid receptors mutated at a histidine residue lining the opioid binding cavity.
    Spivak CE, Beglan CL, Seidleck BK, Hirshbein LD, Blaschak CJ, Uhl GR, Surratt CK.
    Mol Pharmacol; 1997 Dec 15; 52(6):983-92. PubMed ID: 9415708
    [Abstract] [Full Text] [Related]

  • 19. Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor binding.
    Feigenbaum JJ, Simantov R.
    Neurosci Lett; 1996 Jul 05; 212(1):5-8. PubMed ID: 8823749
    [Abstract] [Full Text] [Related]

  • 20. Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by mu- but not epsilon-opioid receptor agonist in the mouse.
    Narita M, Ohsawa M, Mizoguchi H, Kamei J, Tseng LF.
    Neuroscience; 1997 Jan 05; 76(1):291-8. PubMed ID: 8971779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.